Drug Companies and PBMs Are Both Major Reasons for High Drug Costs
As November turns to December, consumer advocates, stakeholders, legislative staff, and legislators are getting ready for the next...
Monopolies in America Are A Growing Problem-And the Health Care Industry Is a Perfect Example of Thi
Every antitrust expert knows that monopolies are harmful to consumers, and that in recent years concentration has become a major problem...
Patients Bear the Cost of Rising Drug Prices
A new, thoroughly researched article by STAT News examines how a couple of drug companies raised prices for their best-selling arthritic...
Rep. Jan Schakowsky Promises Action on Lowering Drug Prices
Yesterday morning Roll Call hosted the event "Election Impact: Improving Patient Care Under a New Congress." The most prominent speaker...
Democrats Take Control of House of Representatives, Open Up Opportunity for Lowering Drug Prices
In yesterday's midterm elections, Democrats took control of the House of Representatives in a sweeping victory which was implicitly a...
New Provision in NAFTA Treaty Will Harm Efforts to Lower Drug Prices Through Generic Competition
President Trump declared that lowering prescription drug prices was one of his highest priorities. However, his renegotiation of the...
